Work

Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target

Year: 2018

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-18-1469

Authors: Thomas Grellety, Celine Callens, Elodie Richard, Adrien Briaux, Valérie Vélasco, Marina Pulido, Anthony Gonçalves, Pierre Gestraud, Gaetan MacGrogan, Hervé Bonnefoi, Bruno Cardinaud

Institutions: Université de Bordeaux, Inserm, Institut Bergonié, Institut Curie, Centre d'Investigation Clinique Plurithématique de Bordeaux, Centre National de la Recherche Scientifique, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Université Paris Sciences et Lettres, École Nationale Supérieure des Mines de Paris, Institut Polytechnique de Bordeaux

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, Genentech, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering

Awards: G1420609810, Development of a Novel Peptide Platform for Targeted PET Imaging and Radiotherapy of Breast Cancer, Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer

OpenAlex ID: W2897488461

FWCI: 0.755

Cites: 46

Cited by: 26

Related to: 10